FOXP3+ Regulatory T Cells And Age-Related Diseases

    February 2021 in “ FEBS Journal
    Biaolong Deng, Weiqi Zhang, Yicheng Zhu, Yangyang Li, Dan Li, Bin Li
    TLDR Targeting regulatory T cells may help treat age-related diseases.
    The document reviewed the role of FOXP3+ regulatory T cells (Tregs) in age-related diseases, emphasizing their importance in maintaining immune balance and their potential in therapeutic applications. Tregs were crucial in promoting hair-follicle regeneration and maintaining homeostasis in various tissues. Their imbalance with Th17 cells contributed to chronic inflammation in the elderly, leading to diseases like cancer and cardiovascular disorders. Clinical trials explored Treg-targeting antibodies for conditions such as type 1 diabetes, though potential adverse effects required attention. The review highlighted the need for further research to enhance the safety and specificity of Treg-based therapies and suggested that understanding Treg dynamics and targeting specific pathways could restore immune homeostasis and treat age-related conditions.
    Discuss this study in the Community →